Psychemedics Corporation - PMD

SEC Filings Our PMD Tweets

About Gravity Analytica

Recent News

  • 07.31.2026 - The Difference Between Passing a Drug Test and Managing Risk
  • 07.28.2026 - The Early Signals of Risky Behavior in Student Populations
  • 07.21.2026 - The Role of Laboratory Science in Building Trust
  • 06.30.2026 - Psychemedics Releases 2026 Education Insights Report
  • 06.25.2026 - New Study of 1.2 Million Driver Drug Tests Reveals a Critical Safety Gap
  • 06.16.2026 - The Psychology of Concealment – Why People Outperform Urine Tests but Not Hair Tests
  • 06.09.2026 - Healthcare Hiring Risks – How Hair Testing Adds a Layer of Protection
  • 05.14.2026 - From Raves to Greek Life – Understanding High-Risk Environments for Students
  • 05.07.2026 - Why Turnaround Time Matters
  • 04.23.2026 - Creating Parent Buy‑In – Communicating the Value of Drug Prevention Programs

Recent Filings

  • 03.24.2025 - 10-K Annual report [Section 13 and 15(d), not S-K Item 405]
  • 03.19.2025 - S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments
  • 03.19.2025 - S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments
  • 03.19.2025 - S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments
  • 03.19.2025 - S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments
  • 03.19.2025 - S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments
  • 03.19.2025 - S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments
  • 03.19.2025 - S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments
  • 01.02.2025 - 15-12G Securities registration termination [Section 12(g)]
  • 12.17.2024 - 4 Statement of changes in beneficial ownership of securities